Results 91 to 100 of about 135,031 (119)

Efficacy of Tucidinostat Pre-emptive Therapy for Peripheral T-cell Lymphoma after Allogeneic Stem Cell Transplantation. [PDF]

Intern Med
Takada K, Tachi N, Shonai T, Kawasaki K, Sone T, Ogata H, Kato S, Kobayashi S, Kimura F.   +8 more
europepmc   +1 more source

CD20-positive peripheral T-cell lymphoma not otherwise specified: a case series and review of the literature. [PDF]

Front Oncol
Zhou P, Wang L, Pei X, Yang L, Zhou Y, Ma R, Chen Y, Zhu Z, Yuan X.   +8 more
europepmc   +1 more source

Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach. [PDF]

Mod Pathol
Amador C, Weisenburger DD, Gomez A, Bouska A, Alshomrani A, Alshomrani A, Sharma S, Shah AR, Greiner TC, Vega F, Rosenwald A, Ott G, Feldman AL, Jaffe ES, Ozkaya N, Ondrejka SL, Cook JR, Raess PW, Savage KJ, Slack GW, Song JY, Scott DW, Campo E, Rimsza LM, Khoury JD, Staudt LM, Chan WC, Iqbal J, Leukemia and Lymphoma Molecular Profiling Project Consortium.   +28 more
europepmc   +1 more source

Peripheral T-Cell Lymphoma Mimicking Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids: A Case Report with Confirmatory Brain Biopsy and Longitudinally Extensive Transverse Myelitis. [PDF]

Case Rep Neurol
Shen X, Su N, Zhang L, Zhang Y, Zhao D, Chen Q, Qian H, Yin H, Zhu Y.   +8 more
europepmc   +1 more source

Discrete genetic subtypes and tumor microenvironment signatures correlate with peripheral T-cell lymphoma outcomes. [PDF]

Leukemia
Suehara Y, Sakamoto K, Fujisawa M, Fukumoto K, Abe Y, Makishima K, Suma S, Sakamoto T, Hattori K, Sugio T, Kato K, Akashi K, Matsue K, Narita K, Takeuchi K, Carreras J, Nakamura N, Chiba K, Shiraishi Y, Miyano S, Ogawa S, Chiba S, Sakata-Yanagimoto M.   +22 more
europepmc   +1 more source

The Role of Allogeneic Stem Cell Transplantation in Adult Patients With Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis. [PDF]

Clin Med Insights Oncol
Alazzam A, Said M, AlElaimat M, Alramahi O, Barakat A.   +4 more
europepmc   +1 more source

Case series of long-term responders to pralatrexate in peripheral T-cell lymphoma. [PDF]

J Clin Exp Hematop
Tomita N, Kitazume K, Kitajima T, Hayata H, Sato S, Nakamura N.   +5 more
europepmc   +1 more source

Aggressive GATA-3 Positive Primary Cutaneous Peripheral T-Cell Lymphoma - Not Otherwise Specified Masquerading as CD-4 Positive Small/Medium T-Cell Lymphoproliferative Disorder: Where is the Line of Delineation?

Indian J Dermatol
Kapetanovic I, Bosic M, Zivanovic D.
europepmc   +1 more source

Erratum for the Research Article, "Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroup" by W.G. Lone <i>et al</i>.

Sci Adv
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management

Ca-A Cancer Journal for Clinicians, 2020
Enrica Marchi
exaly